Chan Gerald Insider Trades

Insider Trading History

Track insider trading activity for Chan Gerald. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$1.05M 25,666 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$10.1M 245,844 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.05M 25,666 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$569k 22,645 shares
$25.12
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $726k 17,705 shares
Last Trade
Jan 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$357k 11,199 shares
$31.91
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $469k 11,438 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$344k 5,748 shares
$59.86
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $351k 8,554 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$604k 12,784 shares
$47.28
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.13M 27,600 shares
Last Trade
Jan 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 27,600 shares
$57.20
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $1.13M 27,600 shares
Last Trade
Jan 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$845k 27,600 shares
$30.62
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $721k 17,580 shares
Last Trade
Jan 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 17,580 shares
$13.19
$41.03
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $808k 20,000 shares
Last Trade
Jun 06, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$660k 20,000 shares
$33.00
$40.39
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2017 Sale
No data
No data
$41.03
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $525k 13,000 shares
Last Trade
Jun 08, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$686k 13,000 shares
$52.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $525k 13,000 shares
Last Trade
Jun 09, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$807k 13,000 shares
$62.10
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $808k 20,000 shares
Last Trade
Apr 14, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Director
Holding Value $0 0 shares
Last Trade
Apr 14, 2015 Sale
No data
No data
$40.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up